Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37726 - 37750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	LRAT	9227	upregulated	entinostat results in increased expression of LRAT mRNA	4q32.1	A21035
Entinostat	Investigational	LRCH1	23143	downregulated	entinostat results in decreased expression of LRCH1 mRNA	13q14.13-q14.2	A21035
Entinostat	Investigational	LRFN1	57622	upregulated	entinostat results in increased expression of LRFN1 mRNA	19q13.2	A21035
Entinostat	Investigational	LRP2	4036	downregulated	entinostat results in decreased expression of LRP2 mRNA	2q31.1	A21037
Entinostat	Investigational	LRP2	4036	upregulated	entinostat results in increased expression of LRP2 mRNA	2q31.1	A21035
Entinostat	Investigational	LRRC17	10234	upregulated	entinostat results in increased expression of LRRC17 mRNA	7q22.1	A21037
Entinostat	Investigational	LRRC3B	116135	downregulated	entinostat results in decreased expression of LRRC3B mRNA	3p24.1	A21037
Entinostat	Investigational	LRRC4	64101	downregulated	entinostat results in decreased expression of LRRC4 mRNA	7q32.1	A21037
Entinostat	Investigational	LRRC55	219527	downregulated	entinostat results in decreased expression of LRRC55 mRNA	11q12.1	A21037
Entinostat	Investigational	LRRC8A	56262	downregulated	entinostat results in decreased expression of LRRC8A mRNA	9q34.11	A21035
Entinostat	Investigational	LRRC8B	23507	downregulated	entinostat results in decreased expression of LRRC8B mRNA	1p22.2	A21037
Entinostat	Investigational	LRRC8C	84230	downregulated	entinostat results in decreased expression of LRRC8C mRNA	1p22.2	A21037
Entinostat	Investigational	LRRC8C	84230	upregulated	entinostat results in increased expression of LRRC8C mRNA	1p22.2	A21035
Entinostat	Investigational	LRRC8E	80131	upregulated	entinostat results in increased expression of LRRC8E mRNA	19p13.2	A21037 A21035
Entinostat	Investigational	LRRFIP1	9208	upregulated	entinostat results in increased expression of LRRFIP1 mRNA	2q37.3	A21037
Entinostat	Investigational	LRRK1	79705	upregulated	entinostat results in increased expression of LRRK1 mRNA	15q26.3	A21037
Entinostat	Investigational	LRRN3	54674	upregulated	entinostat results in increased expression of LRRN3 mRNA	7q31.1	A21037
Entinostat	Investigational	LSAMP	4045	downregulated	entinostat results in decreased expression of LSAMP mRNA	3q13.31	A21037
Entinostat	Investigational	LSM8	51691	downregulated	entinostat results in decreased expression of LSM8 mRNA	7q31.31	A21037
Entinostat	Investigational	LTBP2	4053	upregulated	entinostat results in increased expression of LTBP2 mRNA	14q24.3	A21035
Entinostat	Investigational	LY75	4065	upregulated	entinostat results in increased expression of LY75 mRNA	2q24.2	A21037
Entinostat	Investigational	LYN	4067	upregulated	entinostat results in increased expression of LYN mRNA	8q12.1	A21037
Entinostat	Investigational	LYPD3	27076	upregulated	entinostat results in increased expression of LYPD3 mRNA	19q13.31	A21037 A21035
Entinostat	Investigational	LYZL6	57151	upregulated	entinostat results in increased expression of LYZL6 mRNA	17q12	A21037 A21035
Entinostat	Investigational	LZTS1	11178	upregulated	entinostat results in increased expression of LZTS1 mRNA	8p21.3	A21037

Displaying entries 37726 - 37750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability